Mild Moderate
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy Subjects (NCT01442259) | Novartis Pharmaceuticals | 2011-01-01 |
Track Mild Moderate automatically
Every clearance here is in the API, with alerts when new ones post.